Evaluation of the effectiveness of remdesivir in severe COVID-19 using observational data from a prospective national cohort study (2021)

First Author: Arch B

Attributed to: ISARIC - Coronavirus Clinical Characterisation Consortium (ISARIC-4C) funded by COVID

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1101/2021.06.18.21259072

Publication URI: http://dx.doi.org/10.1101/2021.06.18.21259072

Type: Preprint